Gastrointestinal discomfort (e.g., nausea, bloating, cramping)
For moderate to severe withdrawal symptoms, consider increasing the opioid to the previous dosage, especially if gastrointestinal symptoms are present or consider restarting or supplementing with benzodiazepine therapy
The PCAC will review the available clinical evidence in deciding whether to recommend adding these peptides to the FDA bulk compounding list
Le R, Nguyen MT, Allahwala MA, Psaltis JP, Marathe CS, Marathe JA, Psaltis PJ: Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs
You may want to consult with a dermatologist before use if you have specific scalp concerns, too
at (213) 753-0511 to explore personalized treatment options designed to reduce your symptoms and improve your quality of life